ISSN 1662-4009 (online)

ey0015.9-12 | Biologic agents in chronic inflammatory diseases: lights and shadows | ESPEYB15

9.12 Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn’s Disease

TD Walters , WA Faubion , AM Griffiths , RN Baldassano , J Escher , FM Ruemmele , JS Hyams , A Lazar , S Eichner , B Huang , Y Li , RB Thakkar

To read the full abstract: Inflamm Bowel Dis. 2017;23:967-975Approximately one-third of children and adolescents with Crohn disease (CD) suffer from growth failure and delayed puberty, leading in some to psychological and social dysfunction, especially in boys. Pubertal delay in CD may also impact the normal growth spurt and lead to short adult height. The aim of therapy in children with C...